Patents by Inventor Kenneth Drasner

Kenneth Drasner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110178079
    Abstract: Novel guanidine compounds having the formula in which R1, R2, and R4 are as defined, are effective as sodium channel dockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.
    Type: Application
    Filed: March 30, 2011
    Publication date: July 21, 2011
    Inventors: Kenneth Drasner, Kevin T. Weber
  • Publication number: 20110166181
    Abstract: Novel guanidine compounds having the formula in which R1, R2 and R4 are as defined, are effective as sodium channel dockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.
    Type: Application
    Filed: December 7, 2010
    Publication date: July 7, 2011
    Inventors: Kenneth Drasner, Kevin T. Weber
  • Patent number: 7868028
    Abstract: Novel guanidine compounds having the formula in which R1, R2 and R4 are as defined, are effective as sodium channel blockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.
    Type: Grant
    Filed: June 17, 2002
    Date of Patent: January 11, 2011
    Inventors: Kenneth Drasner, Kevin T. Weber
  • Publication number: 20050228022
    Abstract: Novel guanidine compounds having the formula in which R1, R2 and R4 are as defined, are effective as sodium channel blockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.
    Type: Application
    Filed: June 17, 2002
    Publication date: October 13, 2005
    Applicant: Taktix Corporation
    Inventors: Kenneth Drasner, Kevin Weber
  • Patent number: 5234406
    Abstract: The catheter system for delivering an anesthetic solution to the subarachnoid space of a patient comprises a small diameter catheter section joined to a larger diameter extension tube. The small diameter catheter section is introduced to the subarachnoid space, typically using an introducer needle, and anesthetic can be delivered to the catheter section through the large diameter tube extension. In this way, total flow resistance to the delivery of the anesthetic is reduced without the corresponding increase in the portion of the catheter which is introduced to the subarachnoid space.
    Type: Grant
    Filed: April 6, 1992
    Date of Patent: August 10, 1993
    Assignee: The Regents of the University of California
    Inventors: Kenneth Drasner, Mark L. Rigler